Silvaco Group (SVCO) Financials

Silvaco Group logo
$6.93 -0.20 (-2.81%)
Closing price 04:00 PM Eastern
Extended Trading
$6.74 -0.19 (-2.73%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Silvaco Group

Annual Income Statements for Silvaco Group

This table shows Silvaco Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.32 -39 -41
Consolidated Net Income / (Loss)
-0.32 -39 -41
Net Income / (Loss) Continuing Operations
-0.32 -39 -41
Total Pre-Tax Income
0.51 -39 -45
Total Operating Income
1.13 -40 -46
Total Gross Profit
45 48 49
Total Revenue
54 60 63
Operating Revenue
54 60 63
Total Cost of Revenue
9.35 12 14
Operating Cost of Revenue
9.35 12 14
Total Operating Expenses
44 88 95
Selling, General & Admin Expense
18 38 34
Marketing Expense
13 18 18
Research & Development Expense
13 21 30
Other Special Charges / (Income)
0.00 11 13
Total Other Income / (Expense), net
-0.62 1.36 1.25
Interest Expense
0.63 0.72 0.00
Interest & Investment Income
0.01 2.98 1.95
Other Income / (Expense), net
- -0.90 -0.70
Income Tax Expense
0.83 0.48 -3.44
Basic Earnings per Share
($0.02) ($1.53) ($1.39)
Weighted Average Basic Shares Outstanding
20M 25.67M 29.74M
Diluted Earnings per Share
($0.02) ($1.53) ($1.39)
Weighted Average Diluted Shares Outstanding
20M 25.67M 29.74M
Weighted Average Basic & Diluted Shares Outstanding
- 28.67M 31.44M

Quarterly Income Statements for Silvaco Group

This table shows Silvaco Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
1.38 -38 -6.55 4.16 -19 -9.41 -5.30 -7.23 -5.86 -3.68 -4.59
Consolidated Net Income / (Loss)
1.38 -38 -6.55 4.16 -19 -9.41 -5.30 -7.23 -5.86 -3.68 -4.59
Net Income / (Loss) Continuing Operations
1.38 -38 -6.55 4.16 -19 -9.41 -5.30 -7.23 -5.86 -3.68 -4.59
Total Pre-Tax Income
2.18 -38 -6.36 3.43 -19 -9.94 -8.94 -6.71 -5.72 -4.35 -4.64
Total Operating Income
2.39 -38 -7.30 2.42 -20 -10 -9.34 -6.78 -5.66 -4.00 -4.29
Total Gross Profit
14 10 8.19 15 11 8.54 15 15 15 15 14
Total Revenue
16 15 11 18 14 12 19 18 18 18 16
Operating Revenue
16 15 11 18 14 12 19 18 18 18 16
Total Cost of Revenue
1.97 4.86 2.79 2.42 3.02 3.50 4.13 3.04 2.42 2.64 2.61
Operating Cost of Revenue
1.97 4.86 2.79 2.42 3.02 3.50 4.13 3.04 2.42 2.64 2.61
Total Operating Expenses
12 48 15 13 31 19 24 22 21 19 18
Selling, General & Admin Expense
4.60 18 7.13 7.53 8.12 8.07 11 6.97 7.01 6.48 6.74
Marketing Expense
3.31 7.17 3.83 3.98 4.72 4.71 4.27 4.61 4.82 3.87 4.04
Research & Development Expense
3.62 7.71 4.13 5.28 4.80 5.91 8.74 10 9.16 8.81 7.19
Other Special Charges / (Income)
0.00 15 0.39 - 13 0.00 0.00 - 0.00 0.00 0.00
Total Other Income / (Expense), net
-0.21 -0.39 0.94 1.01 0.57 0.21 0.40 0.07 -0.07 -0.35 -0.35
Interest & Investment Income
0.00 0.68 1.22 1.28 0.86 0.65 0.32 0.12 0.05 0.03 0.07
Other Income / (Expense), net
- - -0.28 - -0.29 -0.44 0.08 - -0.11 -0.38 -0.42
Income Tax Expense
0.81 0.21 0.19 -0.72 0.21 -0.53 -3.65 0.52 0.14 -0.67 -0.05
Basic Earnings per Share
$0.07 ($1.55) ($0.23) $0.18 ($0.67) ($0.32) ($0.18) ($0.22) ($0.19) ($0.11) ($0.14)
Weighted Average Basic Shares Outstanding
20M 24.81M 29.05M 25.67M 28.69M 29.31M 30.21M 29.74M 31.37M 33.02M 33.96M
Diluted Earnings per Share
$0.07 ($1.55) ($0.23) $0.18 ($0.67) ($0.32) ($0.18) ($0.22) ($0.19) ($0.11) ($0.14)
Weighted Average Diluted Shares Outstanding
20M 24.81M 29.05M 25.67M 28.69M 29.31M 30.21M 29.74M 31.37M 33.02M 33.96M
Weighted Average Basic & Diluted Shares Outstanding
26.29M 26.29M 28.46M 28.67M 29.39M 30.38M 30.64M 31.44M 32.68M 33.89M 34.20M

Annual Cash Flow Statements for Silvaco Group

This table details how cash moves in and out of Silvaco Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.06 15 -2.35
Net Cash From Operating Activities
1.18 -20 -34
Net Cash From Continuing Operating Activities
1.18 -20 -34
Net Income / (Loss) Continuing Operations
-0.32 -39 -41
Consolidated Net Income / (Loss)
-0.32 -39 -41
Depreciation Expense
0.60 1.29 3.47
Amortization Expense
0.00 -1.69 -0.49
Non-Cash Adjustments To Reconcile Net Income
-4.99 29 29
Changes in Operating Assets and Liabilities, net
5.88 -8.97 -25
Net Cash From Investing Activities
-0.34 -67 34
Net Cash From Continuing Investing Activities
-0.34 -67 34
Purchase of Property, Plant & Equipment
-0.34 -0.51 -0.62
Acquisitions
- 0.00 -33
Purchase of Investments
0.00 -100 0.00
Sale of Property, Plant & Equipment
- 0.00 0.03
Sale and/or Maturity of Investments
0.00 34 67
Net Cash From Financing Activities
-1.65 101 -2.21
Net Cash From Continuing Financing Activities
-1.65 101 -2.21
Repayment of Debt
-1.00 -6.84 -1.26
Repurchase of Common Equity
-0.65 -2.65 0.00
Issuance of Debt
1.00 9.10 0.00
Issuance of Common Equity
0.00 106 0.90
Other Financing Activities, net
-1.00 -4.65 -1.85
Effect of Exchange Rate Changes
-0.25 0.19 0.05
Cash Interest Paid
0.07 0.50 0.36
Cash Income Taxes Paid
0.66 0.63 0.55

Quarterly Cash Flow Statements for Silvaco Group

This table details how cash moves in and out of Silvaco Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
1.32 29 -7.67 -7.00 9.88 0.14 -5.31 -7.06 -6.33 2.08 9.01
Net Cash From Operating Activities
-2.57 -6.22 -1.87 -9.11 -1.14 -15 -7.82 -9.48 -11 -5.50 -0.77
Net Cash From Continuing Operating Activities
-2.57 -6.22 -1.87 -9.11 -1.14 -15 -7.82 -9.48 -11 -5.66 -0.62
Net Income / (Loss) Continuing Operations
1.38 -38 -6.55 4.16 -19 -9.41 -5.30 -7.23 -5.86 -3.68 -4.59
Consolidated Net Income / (Loss)
1.38 -38 -6.55 4.16 -19 -9.41 -5.30 -7.23 -5.86 -3.68 -4.59
Depreciation Expense
0.12 0.36 0.43 0.38 0.44 0.71 1.10 1.23 1.27 1.20 1.23
Non-Cash Adjustments To Reconcile Net Income
-3.46 37 2.56 -6.87 16 13 -2.37 3.25 3.21 2.18 1.53
Changes in Operating Assets and Liabilities, net
-0.61 -4.76 2.40 -5.99 2.17 -19 -1.25 -6.70 -9.66 -5.36 1.20
Net Cash From Investing Activities
-0.01 -68 -5.09 6.42 11 16 3.38 2.53 1.00 -0.01 -0.01
Net Cash From Continuing Investing Activities
-0.01 -68 -5.09 6.42 11 16 3.38 2.53 1.00 -0.01 -0.01
Purchase of Property, Plant & Equipment
-0.01 -0.05 -0.29 -0.16 -0.10 -0.13 -0.36 -0.04 0.00 -0.01 -0.01
Net Cash From Financing Activities
3.87 103 -0.88 -4.25 -0.50 -1.10 -0.64 0.02 3.69 7.57 9.92
Net Cash From Continuing Financing Activities
3.87 103 -0.88 -4.25 -0.50 -1.10 -0.64 0.02 3.69 7.57 9.92
Other Financing Activities, net
-0.01 -0.01 -0.05 -4.58 -0.30 -0.33 -0.71 -0.51 -0.30 -0.03 -0.08

Annual Balance Sheets for Silvaco Group

This table presents Silvaco Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
41 142 123
Total Current Assets
21 107 46
Cash & Equivalents
4.42 20 9.01
Restricted Cash
- 0.00 8.25
Short-Term Investments
0.00 63 1.02
Accounts Receivable
4.01 9.21 9.71
Prepaid Expenses
2.55 3.46 4.73
Other Current Assets
9.91 12 13
Plant, Property, & Equipment, net
0.59 0.87 1.53
Total Noncurrent Assets
19 34 75
Goodwill
9.03 9.03 30
Intangible Assets
0.34 4.37 26
Other Noncurrent Operating Assets
10 16 19
Total Liabilities & Shareholders' Equity
41 142 123
Total Liabilities
31 42 48
Total Current Liabilities
25 34 38
Accounts Payable
2.50 3.32 3.48
Accrued Expenses
10 20 19
Current Deferred Revenue
7.88 7.50 11
Current Deferred & Payable Income Tax Liabilities
1.63 1.67 2.49
Other Current Liabilities
0.74 2.21 2.29
Total Noncurrent Liabilities
6.49 7.77 9.25
Long-Term Debt
- - 0.00
Noncurrent Deferred Revenue
5.07 3.59 5.16
Other Noncurrent Operating Liabilities
1.42 4.18 4.09
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
9.40 100 75
Total Preferred & Common Equity
9.40 100 75
Preferred Stock
0.00 0.00 0.00
Total Common Equity
9.40 100 75
Common Stock
0.00 130 146
Retained Earnings
11 -28 -69
Accumulated Other Comprehensive Income / (Loss)
-1.99 -2.27 -1.93

Quarterly Balance Sheets for Silvaco Group

This table presents Silvaco Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
47 149 146 138 128 131 111 115 122
Total Current Assets
24 108 119 100 82 53 38 43 50
Cash & Equivalents
5.74 34 27 29 13 12 11 13 22
Restricted Cash
- - - - 17 12 0.00 0.00 0.00
Short-Term Investments
- 55 74 45 26 3.53 0.00 0.00 0.00
Accounts Receivable
5.56 6.78 5.04 5.78 9.89 7.49 9.19 12 8.46
Prepaid Expenses
1.75 3.37 3.22 4.50 4.63 5.09 4.27 4.83 5.13
Other Current Assets
11 9.18 9.95 15 12 13 14 14 14
Plant, Property, & Equipment, net
0.66 0.74 0.84 0.89 0.99 1.69 1.37 1.27 1.19
Total Noncurrent Assets
22 40 27 37 45 76 72 71 71
Goodwill
9.03 9.03 9.03 14 19 31 30 30 30
Intangible Assets
0.27 4.96 4.66 10.00 13 27 25 24 23
Other Noncurrent Operating Assets
13 13 13 13 13 18 17 17 18
Total Liabilities & Shareholders' Equity
47 149 146 138 128 131 111 115 122
Total Liabilities
37 48 48 55 48 51 35 32 40
Total Current Liabilities
26 40 40 47 39 42 27 25 24
Accounts Payable
3.33 2.57 4.20 2.14 1.85 3.64 3.56 2.59 1.92
Accrued Expenses
9.95 24 23 32 24 23 10 10 10
Current Deferred Revenue
7.94 8.52 7.78 8.62 9.30 11 8.82 8.06 7.59
Current Deferred & Payable Income Tax Liabilities
2.19 2.29 2.45 1.73 1.52 1.46 2.07 0.99 1.05
Other Current Liabilities
0.82 2.91 2.71 1.84 1.98 2.18 2.22 3.28 3.25
Total Noncurrent Liabilities
11 7.53 7.36 7.80 9.43 9.73 7.78 6.48 16
Long-Term Debt
4.28 - - - - - - - 10
Noncurrent Deferred Revenue
4.74 3.34 3.24 3.60 5.21 4.96 4.73 4.69 4.12
Other Noncurrent Operating Liabilities
1.52 4.19 4.12 4.19 4.22 4.78 3.05 1.79 1.83
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
11 102 99 84 80 79 77 84 82
Total Preferred & Common Equity
11 102 99 84 80 79 77 84 82
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
11 102 99 84 80 79 77 84 82
Common Stock
0.00 130 132 133 138 143 154 165 167
Retained Earnings
13 -26 -32 -47 -57 -62 -75 -79 -83
Accumulated Other Comprehensive Income / (Loss)
-2.18 -2.38 -1.43 -2.06 -1.29 -1.68 -2.22 -2.25 -1.91

Annual Metrics And Ratios for Silvaco Group

This table displays calculated financial ratios and metrics derived from Silvaco Group's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 - 30,638,877.00
DEI Adjusted Shares Outstanding
0.00 - 30,638,877.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 - -1.34
Growth Metrics
- - -
Revenue Growth
0.00% 10.02% 5.67%
EBITDA Growth
0.00% -2,444.61% -4.89%
EBIT Growth
0.00% -3,651.94% -13.15%
NOPAT Growth
0.00% -3,912.79% -13.94%
Net Income Growth
0.00% -12,369.62% -4.57%
EPS Growth
0.00% -7,550.00% 9.15%
Operating Cash Flow Growth
0.00% -1,775.76% -71.47%
Free Cash Flow Firm Growth
0.00% 0.00% -125.26%
Invested Capital Growth
0.00% 80.79% 349.35%
Revenue Q/Q Growth
0.00% 0.00% 0.63%
EBITDA Q/Q Growth
0.00% 0.00% -23.52%
EBIT Q/Q Growth
0.00% 0.00% -26.98%
NOPAT Q/Q Growth
0.00% 0.00% -25.08%
Net Income Q/Q Growth
0.00% 0.00% -38.16%
EPS Q/Q Growth
0.00% 0.00% -40.40%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -1.10%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 3.12%
Invested Capital Q/Q Growth
0.00% 826.18% 10.66%
Profitability Metrics
- - -
Gross Margin
82.76% 79.82% 78.29%
EBITDA Margin
3.20% -68.16% -69.16%
Operating Margin
2.09% -67.49% -72.78%
EBIT Margin
2.09% -67.49% -73.88%
Profit (Net Income) Margin
-0.58% -66.03% -65.34%
Tax Burden Percent
-61.96% 101.24% 92.30%
Interest Burden Percent
44.97% 96.63% 95.82%
Effective Tax Rate
161.96% 0.00% 0.00%
Return on Invested Capital (ROIC)
-10.07% -287.68% -92.67%
ROIC Less NNEP Spread (ROIC-NNEP)
-26.04% -262.74% -75.50%
Return on Net Nonoperating Assets (RNNOA)
6.70% 215.70% 45.60%
Return on Equity (ROE)
-3.36% -71.98% -47.07%
Cash Return on Invested Capital (CROIC)
0.00% -345.22% -219.86%
Operating Return on Assets (OROA)
2.77% -43.97% -35.17%
Return on Assets (ROA)
-0.77% -43.01% -31.10%
Return on Common Equity (ROCE)
-3.36% -71.98% -47.07%
Return on Equity Simple (ROE_SIMPLE)
-3.36% -39.37% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.70 -28 -32
NOPAT Margin
-1.30% -47.24% -50.94%
Net Nonoperating Expense Percent (NNEP)
15.97% -24.94% -17.17%
Return On Investment Capital (ROIC_SIMPLE)
-6.16% -28.17% -42.84%
Cost of Revenue to Revenue
17.24% 20.18% 21.71%
SG&A Expenses to Revenue
32.96% 62.95% 53.96%
R&D to Revenue
24.28% 34.75% 47.35%
Operating Expenses to Revenue
80.67% 147.31% 151.06%
Earnings before Interest and Taxes (EBIT)
1.13 -40 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1.74 -41 -44
Valuation Ratios
- - -
Price to Book Value (P/BV)
12.13 2.30 1.65
Price to Tangible Book Value (P/TBV)
3,352.94 2.65 6.57
Price to Revenue (P/Rev)
2.10 3.85 1.97
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
15.98 11.29 1.87
Enterprise Value to Revenue (EV/Rev)
2.06 2.39 1.68
Enterprise Value to EBITDA (EV/EBITDA)
64.31 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
98.39 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
94.56 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
0.21 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00
Financial Leverage
-0.26 -0.82 -0.60
Leverage Ratio
4.35 1.67 1.51
Compound Leverage Factor
1.96 1.62 1.45
Debt to Total Capital
17.54% 0.00% 0.00%
Short-Term Debt to Total Capital
17.54% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
82.46% 100.00% 100.00%
Debt to EBITDA
1.15 0.00 0.00
Net Debt to EBITDA
-1.40 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00
Debt to NOPAT
-2.85 0.00 0.00
Net Debt to NOPAT
3.45 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00
Altman Z-Score
3.86 3.09 0.11
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
0.84 3.11 1.20
Quick Ratio
0.34 2.66 0.51
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
0.00 -34 -76
Operating Cash Flow to CapEx
348.08% -3,915.64% -5,786.01%
Free Cash Flow to Firm to Interest Expense
0.00 -20.92 0.00
Operating Cash Flow to Interest Expense
1.87 -12.23 0.00
Operating Cash Flow Less CapEx to Interest Expense
1.33 -12.54 0.00
Efficiency Ratios
- - -
Asset Turnover
1.33 0.65 0.48
Accounts Receivable Turnover
13.54 9.03 6.67
Inventory Turnover
0.00 0.00 0.00
Fixed Asset Turnover
91.79 81.98 52.77
Accounts Payable Turnover
3.75 4.14 4.03
Days Sales Outstanding (DSO)
26.95 40.42 54.76
Days Inventory Outstanding (DIO)
0.00 0.00 0.00
Days Payable Outstanding (DPO)
97.36 88.07 90.61
Cash Conversion Cycle (CCC)
-70.40 -47.65 -35.86
Capital & Investment Metrics
- - -
Invested Capital
6.98 13 57
Invested Capital Turnover
7.77 6.09 1.82
Increase / (Decrease) in Invested Capital
0.00 5.64 44
Enterprise Value (EV)
112 143 106
Market Capitalization
114 230 124
Book Value per Share
$0.47 $3.52 $2.45
Tangible Book Value per Share
$0.00 $3.05 $0.62
Total Capital
11 100 75
Total Debt
2.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00
Net Debt
-2.42 -87 -18
Capital Expenditures (CapEx)
0.34 0.51 0.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-6.53 -9.89 -11
Debt-free Net Working Capital (DFNWC)
-2.11 73 7.67
Net Working Capital (NWC)
-4.11 73 7.67
Net Nonoperating Expense (NNE)
-0.39 11 9.08
Net Nonoperating Obligations (NNO)
-2.42 -87 -18
Total Depreciation and Amortization (D&A)
0.60 -0.40 2.98
Debt-free, Cash-free Net Working Capital to Revenue
-12.03% -16.56% -16.81%
Debt-free Net Working Capital to Revenue
-3.88% 121.97% 12.17%
Net Working Capital to Revenue
-7.57% 121.97% 12.17%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 ($1.53) ($1.39)
Adjusted Weighted Average Basic Shares Outstanding
0.00 25.67M 29.74M
Adjusted Diluted Earnings per Share
$0.00 ($1.53) ($1.39)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 25.67M 29.74M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 28.67M 31.44M
Normalized Net Operating Profit after Tax (NOPAT)
0.79 -20 -23
Normalized NOPAT Margin
1.46% -33.98% -36.44%
Pre Tax Income Margin
0.94% -65.21% -70.79%
Debt Service Ratios
- - -
EBIT to Interest Expense
1.80 -24.91 0.00
NOPAT to Interest Expense
-1.12 -17.44 0.00
EBIT Less CapEx to Interest Expense
1.26 -25.22 0.00
NOPAT Less CapEx to Interest Expense
-1.65 -17.75 0.00
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
-205.70% -6.72% 0.00%

Quarterly Metrics And Ratios for Silvaco Group

This table displays calculated financial ratios and metrics derived from Silvaco Group's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
0.00 26,294,217.00 26,294,217.00 - 28,672,399.00 29,385,444.00 30,382,107.00 30,638,877.00 31,440,906.00 32,681,239.00 33,885,758.00
DEI Adjusted Shares Outstanding
0.00 26,294,217.00 26,294,217.00 - 28,672,399.00 29,385,444.00 30,382,107.00 30,638,877.00 31,440,906.00 32,681,239.00 33,885,758.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 -1.46 -0.25 - -0.67 -0.32 -0.17 -0.24 -0.19 -0.11 -0.14
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.18% 19.44% -26.58% 43.03% -11.31% -19.47% 70.18% 2.20% 25.99% 47.79% -12.74%
EBITDA Growth
47.62% -60,590.32% -516.25% 213.12% -887.32% 74.39% -3.80% -375.42% 77.30% 68.51% 57.38%
EBIT Growth
55.77% -18,333.66% -535.13% 225.21% -934.30% 73.16% -22.16% -379.62% 71.03% 58.63% 49.13%
NOPAT Growth
45.20% -18,333.66% -460.70% 316.53% -1,011.66% 73.16% -27.94% -261.69% 71.18% 60.57% 54.07%
Net Income Growth
69.29% -11,497.58% -552.42% 285.00% -1,498.62% 75.49% 19.11% -273.80% 69.59% 60.92% 13.46%
EPS Growth
75.00% -7,650.00% -428.57% 263.64% -1,057.14% 79.35% 21.74% -222.22% 71.64% 65.63% 22.22%
Operating Cash Flow Growth
-613.37% -473.69% -2.07% -1,172.67% 55.87% -148.76% -317.35% -4.05% -871.10% 64.45% 90.10%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% -20.69% -21.57% -1,664.61% -1,704.99% -421.26% -55.94% 63.43%
Invested Capital Growth
0.00% 0.00% 0.00% 80.79% -18.82% 5,692.34% 3,048.79% 349.35% 626.46% 193.05% 36.61%
Revenue Q/Q Growth
27.25% -5.85% -26.66% 62.77% -21.09% -14.50% 54.98% -2.25% -2.72% 0.29% -8.49%
EBITDA Q/Q Growth
240.03% -1,600.32% 79.10% 126.71% -1,074.63% 50.47% 15.30% 31.63% 19.66% 29.20% -9.61%
EBIT Q/Q Growth
223.35% -1,682.45% 79.94% 133.20% -921.91% 48.33% 8.71% 26.80% 14.86% 24.12% -7.58%
NOPAT Q/Q Growth
211.23% -1,854.82% 80.68% 157.41% -568.33% 48.33% 7.90% 27.45% 16.54% 29.31% -7.30%
Net Income Q/Q Growth
161.33% -2,885.78% 82.93% 163.46% -563.63% 51.18% 43.68% -36.35% 18.89% 37.25% -24.72%
EPS Q/Q Growth
163.64% -2,314.29% 85.16% 178.26% -472.22% 52.24% 43.75% -22.22% 13.64% 42.11% -27.27%
Operating Cash Flow Q/Q Growth
-402.94% -141.91% 69.90% -386.23% 87.54% -1,263.70% 49.50% -21.22% -16.31% 50.08% 85.93%
Free Cash Flow Firm Q/Q Growth
0.00% -169.72% 87.04% 19.79% -330.34% -171.69% -88.17% 17.96% -24.28% 18.72% 55.87%
Invested Capital Q/Q Growth
59.79% -103.86% -303.25% 826.18% -28.25% 166.16% 112.63% 10.66% 16.00% 7.37% -0.88%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
87.58% 67.51% 74.61% 86.44% 78.60% 70.92% 77.87% 83.34% 86.39% 85.15% 83.99%
EBITDA Margin
15.78% -251.52% -71.66% 11.34% -140.12% -79.98% -43.71% -30.57% -25.25% -17.83% -21.35%
Operating Margin
15.03% -252.60% -66.55% 13.57% -139.31% -84.19% -50.03% -37.14% -31.86% -22.46% -26.33%
EBIT Margin
15.03% -252.60% -69.08% 13.57% -141.38% -84.19% -49.59% -37.14% -32.50% -24.59% -28.91%
Profit (Net Income) Margin
8.67% -256.60% -59.71% 23.28% -136.77% -78.10% -28.38% -39.58% -33.00% -20.65% -28.15%
Tax Burden Percent
63.12% 100.56% 102.95% 121.05% 101.12% 94.71% 59.25% 107.74% 102.38% 84.53% 98.84%
Interest Burden Percent
91.42% 101.02% 83.94% 141.67% 95.67% 97.95% 96.59% 98.94% 99.19% 99.34% 98.49%
Effective Tax Rate
36.88% 0.00% 0.00% -21.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
94.99% 0.00% 0.00% 100.05% -558.58% -273.70% -88.66% -47.29% -39.77% -24.06% -21.32%
ROIC Less NNEP Spread (ROIC-NNEP)
48.77% 0.00% 0.00% 97.33% -543.62% -270.78% -90.60% -42.60% -35.32% -21.49% -13.35%
Return on Net Nonoperating Assets (RNNOA)
2.58% 0.00% 0.00% -79.90% 426.97% 235.45% 65.36% 25.73% 18.83% 9.02% 3.30%
Return on Equity (ROE)
97.57% -37.12% -46.43% 20.15% -131.60% -38.26% -23.30% -21.56% -20.94% -15.04% -18.02%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -345.22% -410.77% -202.43% -153.51% -219.86% -211.31% -136.32% -54.88%
Operating Return on Assets (OROA)
17.72% -98.53% -25.62% 8.84% -88.23% -33.41% -22.44% -17.68% -17.38% -14.68% -16.06%
Return on Assets (ROA)
10.23% -100.09% -22.14% 15.16% -85.35% -30.99% -12.84% -18.84% -17.65% -12.32% -15.63%
Return on Common Equity (ROCE)
97.57% -37.12% -46.43% 20.15% -131.60% -38.26% -23.30% -21.56% -20.94% -15.04% -18.02%
Return on Equity Simple (ROE_SIMPLE)
2.34% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1.51 -26 -5.11 2.93 -14 -7.10 -6.54 -4.74 -3.96 -2.80 -3.00
NOPAT Margin
9.49% -176.82% -46.59% 16.43% -97.52% -58.93% -35.02% -26.00% -22.30% -15.72% -18.43%
Net Nonoperating Expense Percent (NNEP)
46.22% -23.34% -2.87% 2.72% -14.95% -2.93% 1.93% -4.69% -4.45% -2.56% -7.96%
Return On Investment Capital (ROIC_SIMPLE)
8.92% -25.97% -5.18% 2.93% -16.44% -8.92% -8.27% -6.33% -5.16% -3.35% -3.26%
Cost of Revenue to Revenue
12.42% 32.49% 25.39% 13.56% 21.40% 29.08% 22.13% 16.66% 13.61% 14.85% 16.01%
SG&A Expenses to Revenue
28.95% 122.42% 64.97% 42.16% 57.62% 66.95% 58.25% 38.17% 39.50% 36.41% 41.39%
R&D to Revenue
22.76% 51.52% 37.68% 29.58% 34.06% 49.03% 46.80% 57.05% 51.59% 49.48% 44.13%
Operating Expenses to Revenue
72.55% 320.11% 141.16% 72.87% 217.91% 155.10% 127.90% 120.47% 118.25% 107.61% 110.33%
Earnings before Interest and Taxes (EBIT)
2.39 -38 -7.58 2.42 -20 -10 -9.26 -6.78 -5.77 -4.38 -4.71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2.51 -38 -7.86 2.03 -20 -9.64 -8.16 -5.58 -4.48 -3.17 -3.48
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
10.76 4.64 3.81 2.30 1.56 1.74 2.08 1.65 2.90 5.39 3.62
Price to Tangible Book Value (P/TBV)
87.96 5.38 4.43 2.65 2.21 2.87 7.68 6.57 10.24 15.13 10.17
Price to Revenue (P/Rev)
2.04 8.11 6.92 3.85 2.26 2.52 2.62 1.97 3.34 6.22 4.23
Price to Earnings (P/E)
459.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
10.27 0.00 0.00 11.29 6.21 3.45 2.66 1.87 3.22 6.20 4.07
Enterprise Value to Revenue (EV/Rev)
2.05 6.36 5.08 2.39 0.97 1.51 2.18 1.68 3.17 6.04 4.06
Enterprise Value to EBITDA (EV/EBITDA)
45.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
57.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
346.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12
Long-Term Debt to Equity
0.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12
Financial Leverage
0.05 -1.00 -1.02 -0.82 -0.79 -0.87 -0.72 -0.60 -0.53 -0.42 -0.25
Leverage Ratio
4.47 1.47 1.48 1.67 1.97 1.53 1.56 1.51 1.56 1.49 1.57
Compound Leverage Factor
4.09 1.48 1.25 2.37 1.88 1.50 1.51 1.50 1.54 1.48 1.54
Debt to Total Capital
37.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.98%
Short-Term Debt to Total Capital
11.93% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
25.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.98%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
62.71% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 89.02%
Debt to EBITDA
2.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.60
Net Debt to EBITDA
0.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.71
Long-Term Debt to EBITDA
1.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.60
Debt to NOPAT
19.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.70
Net Debt to NOPAT
1.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.82
Long-Term Debt to NOPAT
12.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.70
Altman Z-Score
3.53 5.83 5.25 4.08 1.36 1.69 1.60 1.18 3.45 8.28 4.20
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.92 2.70 2.93 3.11 2.14 2.13 1.27 1.20 1.42 1.72 2.09
Quick Ratio
0.43 2.39 2.61 2.66 1.72 1.27 0.55 0.51 0.75 0.98 1.27
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-9.65 -26 -3.37 -2.71 -12 -32 -60 -49 -61 -49 -22
Operating Cash Flow to CapEx
-25,720.00% -13,526.09% -650.35% -5,656.52% -1,182.29% -12,284.13% -2,183.52% -24,936.84% 0.00% -39,300.00% -11,057.14%
Free Cash Flow to Firm to Interest Expense
-47.06 -24.39 0.00 0.00 0.00 -71.41 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-12.55 -5.83 0.00 0.00 0.00 -34.94 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-12.60 -5.87 0.00 0.00 0.00 -35.22 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.18 0.39 0.37 0.65 0.62 0.40 0.45 0.48 0.53 0.60 0.56
Accounts Receivable Turnover
10.04 8.59 10.78 9.03 10.20 6.60 10.01 6.67 8.91 6.74 8.80
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
85.13 78.54 64.42 81.98 74.88 63.44 49.43 52.77 59.00 64.06 48.57
Accounts Payable Turnover
2.79 4.58 2.93 4.14 4.79 5.30 3.34 4.03 4.60 5.51 3.86
Days Sales Outstanding (DSO)
36.35 42.47 33.85 40.42 35.77 55.34 36.46 54.76 40.96 54.16 41.50
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
130.74 79.63 124.52 88.07 76.28 68.86 109.36 90.61 79.37 66.24 94.66
Cash Conversion Cycle (CCC)
-94.39 -37.16 -90.67 -47.65 -40.51 -13.52 -72.90 -35.86 -38.41 -12.09 -53.16
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
11 -0.43 -1.74 13 9.06 24 51 57 66 71 70
Invested Capital Turnover
10.01 -270.44 -62.49 6.09 5.73 4.64 2.53 1.82 1.78 1.53 1.16
Increase / (Decrease) in Invested Capital
11 -0.43 -1.74 5.64 -2.10 25 53 44 57 47 19
Enterprise Value (EV)
115 370 276 143 56 83 137 106 212 438 285
Market Capitalization
114 473 376 230 131 139 164 124 223 451 297
Book Value per Share
$0.53 $3.87 $3.75 $3.52 $2.92 $2.71 $2.60 $2.45 $2.44 $2.56 $2.42
Tangible Book Value per Share
$0.06 $3.34 $3.23 $3.05 $2.07 $1.65 $0.70 $0.62 $0.69 $0.91 $0.86
Total Capital
17 102 99 100 84 80 79 75 77 84 92
Total Debt
6.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10
Total Long-Term Debt
4.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10
Net Debt
0.56 -102 -100 -87 -75 -55 -28 -18 -11 -13 -12
Capital Expenditures (CapEx)
0.01 0.05 0.29 0.16 0.10 0.13 0.36 0.04 0.00 0.01 0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.72 -21 -22 -9.89 -21 -12 -17 -11 0.28 5.16 4.13
Debt-free Net Working Capital (DFNWC)
0.02 68 78 73 53 44 11 7.67 11 18 26
Net Working Capital (NWC)
-2.00 68 78 73 53 44 11 7.67 11 18 26
Net Nonoperating Expense (NNE)
0.13 12 1.44 -1.22 5.53 2.31 -1.24 2.48 1.90 0.88 1.58
Net Nonoperating Obligations (NNO)
0.56 -102 -100 -87 -75 -55 -28 -18 -11 -13 -12
Total Depreciation and Amortization (D&A)
0.12 0.16 -0.28 -0.40 0.18 0.51 1.10 1.20 1.29 1.21 1.23
Debt-free, Cash-free Net Working Capital to Revenue
-10.24% -35.54% -40.96% -16.56% -36.90% -21.77% -26.50% -16.81% 0.42% 7.11% 5.89%
Debt-free Net Working Capital to Revenue
0.03% 116.97% 143.90% 121.97% 91.87% 79.16% 17.93% 12.17% 16.80% 25.05% 37.29%
Net Working Capital to Revenue
-3.58% 116.97% 143.90% 121.97% 91.87% 79.16% 17.93% 12.17% 16.80% 25.05% 37.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.07 ($1.55) ($0.23) $0.18 ($0.67) ($0.32) ($0.18) ($0.22) ($0.19) ($0.11) ($0.14)
Adjusted Weighted Average Basic Shares Outstanding
20M 24.81M 29.05M 25.67M 28.69M 29.31M 30.21M 29.74M 31.37M 33.02M 33.96M
Adjusted Diluted Earnings per Share
$0.07 ($1.55) ($0.23) $0.18 ($0.67) ($0.32) ($0.18) ($0.22) ($0.19) ($0.11) ($0.14)
Adjusted Weighted Average Diluted Shares Outstanding
20M 24.81M 29.05M 25.67M 28.69M 29.31M 30.21M 29.74M 31.37M 33.02M 33.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
26.29M 26.29M 28.46M 28.67M 29.39M 30.38M 30.64M 31.44M 32.68M 33.89M 34.20M
Normalized Net Operating Profit after Tax (NOPAT)
1.51 -16 -4.84 1.70 -4.59 -7.10 -6.54 -4.74 -3.96 -2.80 -3.00
Normalized NOPAT Margin
9.49% -108.06% -44.08% 9.50% -32.60% -58.93% -35.02% -26.00% -22.30% -15.72% -18.43%
Pre Tax Income Margin
13.74% -255.17% -57.99% 19.23% -135.25% -82.46% -47.90% -36.74% -32.24% -24.43% -28.48%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.65 -35.42 0.00 0.00 0.00 -22.90 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
7.35 -24.79 0.00 0.00 0.00 -16.03 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
11.60 -35.46 0.00 0.00 0.00 -23.18 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
7.30 -24.83 0.00 0.00 0.00 -16.31 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
408.87% -7.34% -7.13% -6.72% 0.00% -1.68% 0.00% 0.00% 0.00% -2.75% -2.84%

Financials Breakdown Chart

Key Financial Trends

Silvaco’s second-quarter 2026 results show improving revenue and a narrower loss, but the company remains dependent on external financing because operating cash flow is still negative. Compared with the restated second quarter of 2025, revenue increased from $12.0 million to $17.8 million, while the net loss narrowed from $9.4 million to $3.7 million. However, Silvaco has not yet reached sustained profitability or positive operating cash flow.

  • Revenue has recovered meaningfully. Q2 2026 revenue rose approximately 48% year over year and was broadly stable sequentially versus $17.8 million in Q1 2026. This is a substantial improvement from the $12.0 million reported in Q2 2025.
  • Gross margins have strengthened. Gross profit was $15.2 million in Q2 2026, representing an estimated gross margin of about 85%, compared with roughly 71% in Q2 2025 and 67% in Q2 2024. The improvement suggests a more favorable revenue mix or lower cost of revenue.
  • Losses are narrowing. The Q2 2026 net loss of $3.7 million improved from a $5.9 million loss in Q1 2026 and a $9.4 million loss in Q2 2025. The operating loss also improved to $4.0 million from $5.7 million sequentially and $10.1 million year over year.
  • Expense trends improved sequentially. Total operating expenses declined to $19.2 million in Q2 2026 from $21.0 million in Q1. Selling, general and administrative, marketing and research and development expenses all decreased from the prior quarter.
  • Liquidity improved during the quarter. Cash and equivalents increased from $10.9 million at the end of Q1 2026 to $13.0 million at the end of Q2. Total current assets rose to $43.3 million, while total current liabilities declined to $25.2 million, producing a current ratio of approximately 1.7.
  • Debt exposure appears limited. The recent balance sheets do not report current or long-term debt, reducing interest-rate and refinancing risk. Interest expense was also absent from the Q2 2026 income statement.
  • Operating cash flow remains negative but improved. Cash used in operating activities was $5.5 million in Q2 2026, better than $11.0 million in Q1 2026 and $15.5 million in Q2 2025. Nevertheless, negative operating cash flow means the business is not yet funding itself.
  • Deferred revenue provides some visibility but has declined. Current and noncurrent deferred revenue totaled approximately $12.8 million at June 30, 2026, down from about $13.6 million in Q2 2025 and $16.3 million in Q3 2025. Deferred revenue can support future revenue recognition, but the recent decline warrants monitoring.
  • Silvaco relied on equity financing to increase cash. The company raised approximately $8.2 million through common-equity issuance in Q2 2026, following $4.0 million in Q1. This helped produce a $2.1 million increase in cash despite negative operating cash flow, but it increases dilution risk.
  • Share dilution has become significant. Weighted-average basic shares increased to 33.0 million in Q2 2026 from 31.4 million in Q1 and 29.3 million in Q2 2025. Continued equity issuance could limit per-share recovery even if the company’s operating results improve.
  • Accumulated losses continue to weaken retained earnings. Retained earnings were negative $78.8 million at June 30, 2026, compared with negative $47.3 million at the end of Q1 2024. This reflects the company’s history of losses and leaves less balance-sheet support for shareholders.
  • Working-capital consumption remains a concern. Changes in operating assets and liabilities used $5.4 million of cash in Q2 2026, following a $9.7 million use in Q1. Accounts receivable also rose to $11.6 million from $9.2 million sequentially, which could pressure cash conversion if collections lag revenue.

Overall, the financial trend is moving in a more favorable direction: revenue is higher, gross margins are stronger and quarterly losses are narrowing. The main issue for investors is whether Silvaco can convert that improvement into positive operating cash flow before additional equity financing is needed. Until profitability and cash generation improve, dilution and liquidity management are likely to remain important risks for SVCO shareholders.

11/16/26 06:14 PM ETAI Generated. May Contain Errors.

Silvaco Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Silvaco Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Silvaco Group's net income appears to be on a downward trend, with a most recent value of -$41.21 million in 2025, falling from -$316 thousand in 2023. The previous period was -$39.40 million in 2024. Check out Silvaco Group's forecast to explore projected trends and price targets.

Silvaco Group's total operating income in 2025 was -$45.90 million, based on the following breakdown:
  • Total Gross Profit: $49.37 million
  • Total Operating Expenses: $95.27 million

Over the last 2 years, Silvaco Group's total revenue changed from $54.25 million in 2023 to $63.06 million in 2025, a change of 16.3%.

In the past 10 quarters, Silvaco Group's cash and equivalents has ranged from $5.74 million in Q1 2024 to $34.27 million in Q2 2024, and is currently $22.01 million as of their latest financial filing in Q3 2026.

Silvaco Group had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2023.

Over the last 2 years, Silvaco Group's book value per share changed from 0.47 in 2023 to 2.45 in 2025, a change of 420.6%.



Financial statements for NASDAQ:SVCO last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners